BCAL Diagnostics Limited reported earnings results for the half year ended December 31, 2021. For the half year, the company reported sales was AUD 0.409334 million compared to AUD 0.075083 million a year ago. Net loss was AUD 1.32 million compared to AUD 0.244687 million a year ago.

Basic loss per share from continuing operations was AUD 0.006 compared to AUD 0.002 a year ago. Diluted loss per share from continuing operations was AUD 0.006 compared to AUD 0.002 a year ago.